General Clinical Chemistry Analyzers and Accessories
Cole-Parmer BURKLE 9805-0200 DRY ICE MAKER
Burkle 9805-0200 Dry Ice Maker, 80 x 60 mm tablets; 250 g
Biotium Creatine Phosphokinase(2ba6), CF488A conjugate, 0.1mg/mL
Creatine kinases (CK) are a large family of isoenzymes that regulate levels of ATP in subcellular compartments. They provide ATP at sites of fluctuating energy demand by the transfer of phosphates between creatine and adenine nucleotides. CKs provide the energy of phosphate hydrolysis necessary to drive the normal function of many cellular systems. In cells, the cytosolic CK enzymes consist of two subunits, which can be either B (brain type) or M (muscle type). There are three different isoenzymes: CKMM, CKBB and CKMB. This MAb recognizes the CKBB isoenzyme and does not react with the B subunit in CKMB. It shows minimal reactivity with other human serum proteinsPrimary antibodies are available purified, or with a selection of fluorescent CF Dyes and other labels. CF Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF405S and CF405M are not recommended for detecting low abundance targets, because blue dyes have lower flu
Anton Paar Light-scattering instrument for characterizing particlesin liquid dispersions. Measures particle size, particle concentration,zeta potential, electrophoretic mobility, molecular mass, transmittance
Litesizer DLS 701 specificationsMeasurement principle: Dynamic Light Scattering (DLS)Measuring range: 0.3 nm to 15 μm* (particle diameter)Measurement angles: 15°, 90°, 175°, Multi-angle particle sizing (MAPS)Min. concentration: 0.1 mg/mL (lysozyme)lower than 0.00001 % (0.1 ppm, Latex 100 nm)Max. concentration: 50 % w/v (sample-dependent)Min. sample volume: 1.5 µLAccuracy: Better than +/-2 % on NIST traceable standardsRepeatability: Better than +/-2 % on NIST traceable standardsParticle Concentration SpecificationsAnalysis model: Mie Theory--Measuring range: 108 - 1013 particles/mL (sample dependent)Size limit: 1 µmMeasurement angles: 15°, 90°, 175°, Multi-angle particle sizing (MAPS)Min. sample volume: 12 µLAccuracy: +/- 10 % (sample dependent)Repeatability: +/- 5 % (sample dependent)Zeta potential specificationsMeasuring principle: Electrophoretic Light Scattering (ELS) / cmPALSMeasuring range: >= +/-1000 mVMobility range: 10-11 m²/V.s to 2 x 10-7 m²/V
Anton Paar Dispersion unit with integrated ultrasonication for liquid measurements in water to disperse particles in liquid medium (up to 2500 µm).
LIQUID FLOW DISPERSION UNITDispersion unit with integrated ultrasonication for liquid measurements inwater to disperse particles in liquid medium (up to 2500 µm).Flexible tank filling volume: 150-600 mL.Automated filling, rinsing, and draining.Minimum requirements to run:- outflow of the liquid (wastewater disposal connection or a tank)Recommended requirements to run:- water supply 0.1 - 3 bar
(CCCC)C#C[Si](C)(C)C | 5g | 525924538](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502696479.jpg-250.jpg)
eMolecules 81353-38-0 | Trimethyl(2-tributylstannylethynyl)silane | Synthonix - Stock | MFCD03844806 | 387.270 | C17H36SiSn | 95.000 | CCCC[Sn](CCCC)(CCCC)C#C[Si](C)(C)C | 5g | 525924538
Trimethyl(2-tributylstannylethynyl)silane | Synthonix - Stock | 81353-38-0 | MFCD03844806 | 387.270 | C17H36SiSn | 95.000 | CCCC[Sn](CCCC)(CCCC)C#C[Si](C)(C)C | 5g | 525924538
(CCCC)C#CC | 1g | 525924058](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502696556.jpg-250.jpg)
eMolecules 64099-82-7 | Tributyl(1-propynyl)tin | Synthonix - Stock | MFCD01863650 | 329.115 | C15H30Sn | 95.000 | CCCC[Sn](CCCC)(CCCC)C#CC | 1g | 525924058
Tributyl(1-propynyl)tin | Synthonix - Stock | 64099-82-7 | MFCD01863650 | 329.115 | C15H30Sn | 95.000 | CCCC[Sn](CCCC)(CCCC)C#CC | 1g | 525924058
Roche Diagnostics Galactose/Arabinose Bio, 4 x 50 tests
This product is intended for quantitative determination of galactose or arabinose in aqueous solutions using the Cedex Bio Analyzer.
Abcam GW 6471, PPAR alpha antagonist, 1MG
MW 619.7 Da, Purity >98%. Potent PPAR alpha antagonist (IC₅₀ = 240 nM). Drives displacement of co-activators from PPAR alpha. Promotes recruitment of co-repressor proteins SMRT and NCoR to ligand binding domain. Inhibits cardiomyocyte differentiation in mouse embryonic stem cells. Causes reduced expression of cardiac sarcomeric proteins and specific genes in a time-dependent manner.
The product is subject to the following: Abcam Restricted Use Statement
Abcam RITA, p53 activator, 5MG
MW 292.4 Da, Purity >98%. p53 activator. Tricyclic thiophene derivative that binds to p53 and induces its accumulation in tumor cells. Prevents p53-HDM2 (MDM2) interaction in vitro and in vivo and affects p53 interaction with several negative regulators. Induces expression of p53 target genes and apoptosis in various tumor cell lines expressing wild-type p53.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Monochlorobimane, 5MG
MW 226.66 Da, Purity >=98%. Monochlorobimane is a cell-permeant probe for quantifying glutathione levels in cells. It is essentially nonfluorescent until it reacts with a thiol group. It readily reacts with several low molecular weight thiols, including cysteine, glutathione, N-acetylcysteine, mercaptopurine, peptides and plasma thiols. The glutathione conjugate of monochlorobimane has an excitation/emission maxima ~394/490 nm.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ponesimod, sphingosine-1-phophate receptor agonist, 1MG
MW 461 Da. Ponesimod is a potent agonist of sphingosine-1-phophate receptor. (S1P₁/EDG-1; IC₅₀s = 6, >10,000, 2,068, 1,956, and 142 nM for S1P₁-S1P₅, respectively, in a radioligand binding assay). Selectively activates S1P₁ in a GTPγS assay (EC₅₀s = 5.7, >10,000, 105, 1,108, and 59.1 nM, for S1P₁-S1P₅, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ticagrelor, P2Y12 receptor antagonist, 25MG
MW 522.6 Da, Purity >98%. Reversible antagonist of the platelet purinergic P2Y12 receptor, the main receptor responsible for ADP-induced platelet aggregation. Changes the conformation of the P2Y12 receptor, resulting in reversible, concentration dependent inhibition of the receptor.
The product is subject to the following: Abcam Restricted Use Statement